(SLE)
AVIZAKIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS IL21 (INTERLEUKIN 21)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-446) [VH (HOMO SAPIENS IGHV1- 46*01 (88.8%) -(IGHD) -IGHJ4*01 (100%)) [8.8.9] (1-116) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 (CH1 R120 (213) (117-214), HINGE 1- 15 (215-229), CH2 M15.1>Y (251), S16>T (253), T18>E (255) (IGHG1V21) (230-339), CH3 E12 (355), M14 (357) (340-444), CHS (445- 446)) (117-446)], (219-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-NL1*01 (86.3%) -IGKJ4*01 (100%)) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA. PROPOSED INN LIST 121(WHOM)
AVIZAKIMABUM(INN)